Company News

News

Company News

Home/News

2021-03-21

Great Bay Bio Officially Launches AI Enabled Cell Culture Media Development Platform, AlfaMedX

[Hong Kong, March 31, 2021] Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”) is pleased to announce that the company’s self-developed AI-enabled cell culture media development platform, AlfaMedX®, is officially launched. AlfaMedX is crea

2021-02-23

GBB Completes USD$3.8M Convertible Note Financing Led by Alibaba Hong Kong Entrepreneurs Fund

[Hong Kong, February 23, 2021] Great Bay Bio Holdings Limited (hereinafter referred to as "GBB") today announced it has completed a USD$3.8M Convertible Note Financing. Alibaba Hong Kong Entrepreneurs Fund (hereinafter referred to as "AEF") led the invest

2021-01-26

The 2020 Online Annual Gathering of Great Bay Bio

[Hong Kong, January 22, 2021]Recently, theGreat Bay Bio Family celebrated the past year’s achievement in a special way.

2020-12-24

Good news! Great Bay Bio Rated as High-Tech Enterprise Once Again

[香港,2020年12月24日] 近日,大湾生物再次获评高新技术企业。 高新技术企业属于国家级荣誉,是指在《国家重点支持的高新技术领域》内持续进行研究开发与技术成果转化,形成企业核心自主知识产权,并以此为基

2020-12-13

Great Bay Bio Awarded

[香港,2020年12月23日] 近日,历时近半年的第三届粤港澳大湾区生物科技创新企业50强评选活动圆满结束,大湾生物荣膺粤港澳大湾区生物科技创新企业50强,并获得“先锋企业”称号。 本次活动由中创产业研究

2020-11-13

Mr. Kingsley Leung, Chairman of Great Bay Bio, Won 2020 Hong Kong Young Industrialist Award

[香港,2020年11月13日] 近日,一年一度的YIAH&IOY颁奖典礼暨晚宴如期举行,专注于以人工智能开发生物医药的大湾生物董事长梁国龙先生被授予“香港青年工业家奖”称号。 香港青年工业家奖(“YIAH

2020-10-15

Boom! Klone4.0, AI-enabled Cell Line Development Platform is here!

[香港,2020年10月15日] 大湾生物控股有限公司自主研发的Klone4.0™平台正式上线,首次将人工智能与细胞株开发深度结合,实现了“快速、高效、优质”的细胞株开发效果,为解决行业痛点开辟了新的思路,或将推动细胞株开发产业进入新的

2019-09-18

Discussion held between Great Bay Bio and Peng Cheng Laboratory

[Hong Kong, September 18, 2019] Recently, Discussion between Great Bay Bio and Peng Cheng Laboratory was successfully
Message